We are live on ! Find out more
SBCM

Silverberg Bernstein Capital Management Portfolio holdings

AUM $261M
1-Year Est. Return 89.93%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+89.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$109M
AUM Growth
+$6M
Cap. Flow
+$1.43M
Cap. Flow %
1.31%
Top 10 Hldgs %
64.05%
Holding
53
New
1
Increased
24
Reduced
13
Closed
1

Top Buys

Rank Stock Value
1
DDD icon
3D Systems Corp
DDD
+$870K
2
DMRC icon
Digimarc Corp
DMRC
+$527K
3
IBM icon
IBM
IBM
+$437K
4
PFE icon
Pfizer
PFE
+$254K
5
PHAR
Pharming Group
PHAR
+$140K

Sector Composition

Rank Sector Weight
1 Technology 74.58%
2 Healthcare 8.53%
3 Industrials 5.11%
4 Energy 4.61%
5 Communication Services 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.71T
$1.14M 1.04%
2,642
KMI icon
27
Kinder Morgan
KMI
$68.7B
$946K 0.87%
42,817
+1,300
+3% +$27.4K
GBDC icon
28
Golub Capital BDC
GBDC
$3.42B
$908K 0.83%
60,100
+1,500
+3% +$22.6K
KD icon
29
Kyndryl
KD
$3.05B
$828K 0.76%
36,020
+480
+1% +$11.7K
AAPL icon
30
Apple
AAPL
$4.57T
$816K 0.75%
3,500
ARAY icon
31
Accuray
ARAY
$34M
$748K 0.69%
415,784
+4,700
+1% +$8.94K
TT icon
32
Trane Technologies
TT
$106B
$719K 0.66%
1,850
APYX icon
33
Apyx Medical
APYX
$171M
$710K 0.65%
572,632
-23,855
-4% -$30.1K
CGNT icon
34
Cognyte Software
CGNT
$680M
$681K 0.62%
100,300
+2,000
+2% +$14.6K
GE icon
35
GE Aerospace
GE
$384B
$548K 0.5%
2,906
+225
+8% +$38.1K
KOPN icon
36
Kopin
KOPN
$791M
$502K 0.46%
687,704
+9,500
+1% +$8.71K
DRS icon
37
Leonardo DRS
DRS
$12B
$488K 0.45%
17,300
NEO icon
38
NeoGenomics
NEO
$2.13B
$371K 0.34%
25,180
PHAR
39
Pharming Group
PHAR
$775M
$339K 0.31%
41,110
+17,675
+75% +$140K
NAGE
40
Niagen Bioscience
NAGE
$247M
$304K 0.28%
83,257
+1,100
+1% +$3.46K
MPLX icon
41
MPLX
MPLX
$59.7B
$303K 0.28%
6,809
ALLT icon
42
Allot
ALLT
$383M
$278K 0.25%
93,572
JPM icon
43
JPMorgan Chase
JPM
$950B
$264K 0.24%
1,254
-195
-13% -$41.1K
CCAP icon
44
Crescent Capital BDC
CCAP
$434M
$264K 0.24%
14,260
PFE icon
45
Pfizer
PFE
$153B
$252K 0.23%
+8,700
New +$254K
RITM icon
46
Rithm Capital
RITM
$5.69B
$159K 0.15%
14,000
+300
+2% +$3.41K
OXSQ icon
47
Oxford Square Capital
OXSQ
$157M
$159K 0.15%
56,048
-16,125
-22% -$47.5K
QUIK icon
48
QuickLogic
QUIK
$257M
$111K 0.1%
14,424
VNRX icon
49
VolitionRx Ltd
VNRX
$9.34M
$85.7K 0.08%
7,131
-100
-1% -$1.29K
DRRX
50
DELISTED
DURECT Corp
DRRX
$62.7K 0.06%
46,791
+1,570
+3% +$2.23K

Similar funds

Silverberg Bernstein Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Silverberg Bernstein Capital Management held 53 positions worth $109M, up 5.8% from $103M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 3.8%. Silverberg Bernstein Capital Management opened 1 new position and exited 1, leaving the 53-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 75% of assets, down from 77% a quarter earlier, followed by Healthcare and Industrials.

  • Silverberg Bernstein Capital Management's largest Q3 2024 buy was Pfizer: 8,700 shares worth $252K.
  • Silverberg Bernstein Capital Management added most to 3D Systems Corp in Q3 2024, an estimated $870K increase.
  • Silverberg Bernstein Capital Management's biggest Q3 2024 reduction was Lantheus, cutting an estimated $267K.
  • Silverberg Bernstein Capital Management fully exited Annaly Capital Management in Q3 2024, selling an estimated $208K.
  • Silverberg Bernstein Capital Management's ten largest holdings make up 64% of its $109M portfolio in Q3 2024.
  • Silverberg Bernstein Capital Management opened 1 new position and closed 1 in Q3 2024.
  • Silverberg Bernstein Capital Management's portfolio value rose 5.8% quarter-over-quarter to $109M.

Based on Silverberg Bernstein Capital Management's 13F filing for Q3 2024, filed 4 Oct 2024.